L-Tyrosine Dosing for Children
For parenteral nutrition in children, L-tyrosine should be dosed at a minimum of 18 mg/kg/day in preterm infants and 94 mg/kg/day in term infants, with no established dosing guidelines for oral supplementation in older children beyond consulting a physician for those under 12 years. 1
Evidence-Based Dosing by Age Group
Preterm Infants (Parenteral Nutrition)
- Minimum dose: 18 mg/kg/day 1
- This represents the lower limit to prevent deficiency states
- Optimal requirement determined by indicator amino acid oxidation method: 74 mg/kg/day 1
- Must be administered as part of complete amino acid solutions with adequate non-protein calories (30-40 kcal per 1g amino acids)
Term Infants (Parenteral Nutrition)
- Recommended dose: 94 mg/kg/day 1
- This is the advisable intake based on Level 1+ evidence with Grade B recommendation
- Should be incorporated into total amino acid intake of 1.5-3.0 g/kg/day
Children and Adolescents
Critical gap in evidence: The guidelines 1 provide comprehensive amino acid dosing for children aged 3-12 years (1.0-2.0 g/kg/day total amino acids) and adolescents (1.0-2.0 g/kg/day), but do not specify L-tyrosine requirements separately for these age groups.
Oral Supplementation Considerations
Homeopathic Formulations
The FDA-labeled homeopathic L-tyrosine product recommends:
- Children ≥12 years and adults: 10 drops up to 3 times daily 2
- Children <12 years: Requires physician consultation 2
- These are homeopathic dilutions (4X, 7X, 12X) 2, not therapeutic amino acid doses
Therapeutic Oral Dosing
Limited pediatric data exists for oral supplementation:
- One case series in nemaline myopathy used 250-3000 mg/day in 4 infants and 1 adolescent, showing improved bulbar function and energy without adverse effects 3
- Adult safety data demonstrates tolerability up to 4 g/day for 4 weeks 4, but this cannot be extrapolated to children
Critical Clinical Caveats
Major limitation: The available guidelines focus exclusively on parenteral nutrition in hospital settings, not oral supplementation for outpatient use. The evidence for oral L-tyrosine supplementation in children is extremely limited.
Contraindications and monitoring:
- L-tyrosine is a precursor to catecholamines; theoretical concerns exist in conditions affecting dopamine metabolism
- In tyrosine hydroxylase deficiency, L-dopa (not L-tyrosine) is the primary treatment 5
- No established upper limits for oral supplementation in children
Practical approach for oral supplementation:
- For children <12 years requiring oral L-tyrosine, dosing must be individualized by a physician based on the specific clinical indication
- The nemaline myopathy data 3 suggests starting conservatively (250 mg/day in infants) and titrating based on response
- Weight-based dosing extrapolated from adult data would suggest maximum 50-60 mg/kg/day, but this lacks pediatric validation
The evidence strongly supports specific parenteral dosing in neonates but provides insufficient guidance for routine oral supplementation in older children, necessitating specialist consultation for non-parenteral use.